Trial Profile
Efficiency and safety of IncobotulinumtoxinA treatment with modulation of spasticity
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 29 Nov 2018
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Muscle spasticity
- Focus Adverse reactions; Therapeutic Use
- 29 Nov 2018 New trial record
- 09 Oct 2018 Results presented at the 22nd International Congress of Parkinson's Disease and Movement Disorders